Literature DB >> 10899019

Immune responses in tuberculosis.

J L Flynn1, J D Ernst.   

Abstract

The initial interaction of Mycobacterium tuberculosis with phagocytes through Toll-like receptors can affect induction of the adaptive response by inflammatory cytokine production, as well as begin the process of bacterial containment by induction of antimycobacterial functions. Advances in T cell research in tuberculosis include identification of antigens recognized by CD8(+) T cells in infected hosts, elucidation of antimycobacterial mechanisms of T cells and the discovery of CD8(+) T cells that recognize antigens presented by a variety of non-classical molecules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899019     DOI: 10.1016/s0952-7915(00)00116-3

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  36 in total

Review 1.  Role of cytokines in the innate immune response to intracellular pathogens.

Authors:  S Stenger; M Röllinghoff
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

3.  Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis.

Authors:  W Peters; H M Scott; H F Chambers; J L Flynn; I F Charo; J D Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

4.  CD8(+) T cells participate in the memory immune response to Mycobacterium tuberculosis.

Authors:  N V Serbina; J L Flynn
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis.

Authors:  Alexander Pedroza-González; Gina S García-Romo; Diana Aguilar-León; Juana Calderon-Amador; Raquel Hurtado-Ortiz; Hector Orozco-Estevez; Bart N Lambrecht; Iris Estrada-García; Rogelio Hernández-Pando; Leopoldo Flores-Romo
Journal:  Int J Exp Pathol       Date:  2004-06       Impact factor: 1.925

6.  In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs.

Authors:  Irina V Lyadova; Evgeny N Tsiganov; Marina A Kapina; Galena S Shepelkova; Vasily V Sosunov; Tatiana V Radaeva; Konstantin B Majorov; Natalya S Shmitova; Henk-Jan van den Ham; Vitaly V Ganusov; Rob J De Boer; Rachael Racine; Gary M Winslow
Journal:  PLoS One       Date:  2010-05-04       Impact factor: 3.240

7.  Evaluation of T cell immune responses in multi-drug-resistant tuberculosis (MDR-TB) patients to Mycobacterium tuberculosis total lipid antigens.

Authors:  A S Shahemabadi; A Zavaran Hosseini; S Shaghsempour; M R Masjedi; M Rayani; M Pouramiri
Journal:  Clin Exp Immunol       Date:  2007-05-09       Impact factor: 4.330

8.  Dietary soy phytoestrogens and ERalpha signalling modulate interferon gamma production in response to bacterial infection.

Authors:  E M Curran; B M Judy; L G Newton; D B Lubahn; G E Rottinghaus; R S Macdonald; C Franklin; D M Estes
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

9.  CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis.

Authors:  Zahra Hasan; Jacqueline M Cliff; Hazel M Dockrell; Bushra Jamil; Muhammad Irfan; Mussarat Ashraf; Rabia Hussain
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

10.  IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia.

Authors:  Helena del Corral; Sara C París; Nancy D Marín; Diana M Marín; Lucelly López; Hanna M Henao; Teresita Martínez; Liliana Villa; Luis F Barrera; Blanca L Ortiz; María E Ramírez; Carlos J Montes; María C Oquendo; Lisandra M Arango; Felipe Riaño; Carlos Aguirre; Alberto Bustamante; John T Belisle; Karen Dobos; Gloria I Mejía; Margarita R Giraldo; Patrick J Brennan; Jaime Robledo; María P Arbeláez; Carlos A Rojas; Luis F García
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.